Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Stemchymal by Steminent Biotherapeutics for Spinocerebellar Ataxia (SCA): Likelihood of Approval
Stemchymal is under clinical development by Steminent Biotherapeutics and currently in Phase II for Spinocerebellar Ataxia (SCA). According to GlobalData,...